#USA #Somerset, NJ #Prostate Cancer #ProCure Proton Therapy #Edward Soffen

Understanding Prostate Cancer Awareness

As the month of September ushers in National Prostate Cancer Awareness Month, ProCure Proton Therapy Center is keen on educating men about the nuances of prostate health, and particularly the implications of Prostate-Specific Antigen (PSA) testing. Dr. Edward Soffen, a seasoned prostate cancer specialist with over 30 years of experience, brings a personal perspective to this crucial topic, urging patients to understand that a 'normal' PSA level does not equate to being in the clear.

The Reality Behind PSA Levels

Dr. Soffen’s journey started when he noticed a fluctuation in his own PSA levels. Despite being lower than six months prior, his urologist flagged the results as 'labile,' prompting further investigation through a urine DNA test. This test indicated a concerning 50% malignancy risk. Following up with an MRI and biopsy, the dreaded diagnosis of cancer was confirmed. This highlight emphasizes a significant point: even PSA levels that fall within the standard range of under 4 ng/mL require attention, especially if there's any notable change.

"My experience serves as a cautionary tale; a lot can be missed if you only rely on PSA tests, which are subject to variability," Dr. Soffen pointed out. He advocates for alerting healthcare providers about any changes in PSA levels, as they can lead to earlier interventions that could potentially be life-saving.

Choosing the Right Treatment

After considering various treatment options, Dr. Soffen ruled out surgery due to its associated risks of complications. He then evaluated several radiation therapies he had previously administered, including CyberKnife, brachytherapy, and traditional radiation techniques. Ultimately, he opted for proton therapy, appreciating its precision in targeting tumors while preserving surrounding healthy tissue.

"It was protons for me, hands down," he emphasized, conveying no regrets over his decision. His case is a testament to the adage that informed decision-making, particularly early in the diagnostic process, can lead to better outcomes.

Raising Awareness: A Collective Responsibility

In a broader scope, Dr. Brian Chon, Medical Director at ProCure, echoed Dr. Soffen's sentiments, stating, "We want men to understand that PSA tests alone don’t tell the full story. Tracking trends over time and conducting additional tests when fluctuations are observed can make a significant difference in achieving early diagnosis."

The implications are stark: ensuring that men remain vigilant about their prostate health can transform the approach to prostate cancer diagnosis and treatment. ProCure encourages individuals to prioritize their health and be proactive when it comes to discussions with their physicians regarding any unusual changes in their health metrics.

About ProCure Proton Therapy Center

Established in March 2012, ProCure Proton Therapy Center in Somerset, NJ, represents the first proton therapy facility in the tri-state area. The center specializes in a variety of cancers, including prostate cancer, and has treated over 8,000 patients, including many children. ProCure’s advanced radiation treatment options provide personalized, non-surgical therapies that often come with fewer side effects and reduced recovery times, allowing patients to focus on enjoying their lives.

For further information about the services offered, please visit ProCure.com.

To sum up, as we observe Prostate Cancer Awareness Month, let this be a moment of reflection and education, emphasizing the importance of comprehensive health checks and proactive discussions about prostate health to ensure that no one falls through the cracks of early diagnosis.